GB1110504A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB1110504A
GB1110504A GB1208566A GB1208566A GB1110504A GB 1110504 A GB1110504 A GB 1110504A GB 1208566 A GB1208566 A GB 1208566A GB 1208566 A GB1208566 A GB 1208566A GB 1110504 A GB1110504 A GB 1110504A
Authority
GB
United Kingdom
Prior art keywords
lysozyme
salt
contain
histaminic
toxic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1208566A
Inventor
Rodolfo Ferrari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Prodotti Antibiotici SpA
Original Assignee
Prodotti Antibiotici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prodotti Antibiotici SpA filed Critical Prodotti Antibiotici SpA
Priority to GB1208566A priority Critical patent/GB1110504A/en
Priority to BE695717D priority patent/BE695717A/xx
Publication of GB1110504A publication Critical patent/GB1110504A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Pharmaceutical compositions having anti-bacterial, anti-viral, anaesthetic, analgesic and anti-leukopenic effects comprise a neutral salt of lysozyme with a non-toxic, stable, inorganic or organic acid and an anti-histaminic compound which is completely compatible with said salt of lysozyme. The composition may contain 50-1000 parts by weight of the lysozyme salt per part by weight of anti-histaminic compound. Antihistaminics specified include chlorpheniramine, polaramine, parabromdylamine, carbinoxamine, diphenhydramine and pyrilamine. Salts of lysozyme and the antihistaminic may be formed with hydrochloric, sulphuric, phosphoric, acetic, maleic, citric and tartaric acids. The compositions may also contain a solid or liquid pharmaceutical carrier and may be formulated as tablets and capsules, preferably enteric-coated, or as a sterile, isotonic, aqueous solution buffered to pH 4-6.5 with a phosphate, citrate or tartrate buffer. Such a solution may additionally contain a non-toxic, water-soluble salt (e.g. Na, Cl, Ca Cl2, Na2SO4 and sodium phosphates) and/or a polymeric material (e.g. polyvinyl pyrrolidone and dextran).
GB1208566A 1966-03-18 1966-03-18 Pharmaceutical compositions Expired GB1110504A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB1208566A GB1110504A (en) 1966-03-18 1966-03-18 Pharmaceutical compositions
BE695717D BE695717A (en) 1966-03-18 1967-03-17

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1208566A GB1110504A (en) 1966-03-18 1966-03-18 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB1110504A true GB1110504A (en) 1968-04-18

Family

ID=9998141

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1208566A Expired GB1110504A (en) 1966-03-18 1966-03-18 Pharmaceutical compositions

Country Status (2)

Country Link
BE (1) BE695717A (en)
GB (1) GB1110504A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466449A (en) * 1988-05-26 1995-11-14 Nika Health Products, Ltd. Antibacterial composition and method of use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466449A (en) * 1988-05-26 1995-11-14 Nika Health Products, Ltd. Antibacterial composition and method of use
US6099835A (en) * 1988-05-26 2000-08-08 Nika Health Products Limited Method of using antiviral composition

Also Published As

Publication number Publication date
BE695717A (en) 1967-09-01

Similar Documents

Publication Publication Date Title
PT87329A (en) PROCESS FOR PREPARING A STABILIZED HYDROGEN PEROXIDE SOLUTION FOR DISINFECTING CONTACT LENS
SE8900828L (en) ANTIVIRAL AND IMMUNSTIMULATING PHARMACEUTICAL COMPOSITIONS AND PROCEDURES FOR PREPARING THEM
GB1110504A (en) Pharmaceutical compositions
KR880009973A (en) Crystallized cefem-acid addition salt and preparation method thereof
YU143184A (en) Process for making derivatives of benzo acid having antimicrobic effect
NO177484C (en) Process for the preparation of a pharmaceutical composition in the form of soft capsules
GB954268A (en) Decongestant compositions comprising n-acylated sulphydryl compounds
SE7702078L (en) ANTIBIOTICS
EP0135963A3 (en)
GB1525296A (en) Antibacterial compositions
IE43125L (en) Aminoglycoside derivative
GB668968A (en) Colloidal iodine preparation and method of making the same
GB856493A (en) Therapeutic compositions comprising tetracycline antibiotics
GB899218A (en) Improvements in or relating to therapeutically active organoarsenic compounds
KR890007731A (en) Protein derivatives containing iron in biologically very useful forms, preparations thereof, and pharmaceutical compositions containing the compounds
GB1015800A (en) Improvements in or relating to nicotinic acid derivatives
FR2616149B1 (en) NOVEL DERIVATIVE OF BENZO (B) THIOPHENE - 7 CARBOXYLIC ACID, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
GB982871A (en) Therapeutic compositions containing cysteine compounds
GB874415A (en) Antibacterial agents
GB840917A (en) Water-soluble derivatives of threo-1-p-nitrophenyl-2-azidoacetylaminopropan-1, 3-diols
GB967475A (en) Improvements in or relating to pharmaceutical compositions comprising a salt of (n-methylene-sulphoxylate)-4-amino-2-hydroxybenzoic acid
GB1227042A (en)
GB897480A (en) Improvements in or relating to synthetic inorganic pulverulent carriers and to pesticidal compositions containing them
GB767794A (en) Aqueous chlorine dioxide antiseptic compositions and production thereof
GB997823A (en) Improved pharmaceutical solutions of sodium antimonylgluconate and the production thereof